Diabetes 52:244-251, 2003
© 2003 by the American Diabetes Association, Inc.
Increased Intramyocellular Lipid Concentration Identifies Impaired Glucose Metabolism in Women With Previous Gestational Diabetes
Alexandra Kautzky-Willer1,
Martin Krssak1,
Christine Winzer1,
Giovanni Pacini2,
Andrea Tura2,
Serdar Farhan1,
Oswald Wagner3,
Georg Brabant4,
Rüdiger Horn4,
Harald Stingl1,
Barbara Schneider5,
Werner Waldhäusl1, and
Michael Roden1
1 Department of Internal Medicine III, Division of Endocrinology and Metabolism, University of Vienna, Vienna, Austria
2 Metabolic Unit, Institute of Biomedical Engineering, National Research Council (ISIB-CNR), Padova, Italy
3 Institute for Medical Laboratory Diagnostics, University of Vienna, Vienna, Austria
4 Division of Endocrinology, University of Hannover, Hannover, Germany
5 Institute of Biostatistics, University of Vienna, Vienna, Austria
Women with previous gestational diabetes (pGDM) are frequently insulin-resistant, which could relate to intramyocellular lipid content (IMCL). IMCL were measured with 1H nuclear magnetic resonance spectroscopy in soleus (IMCL-S) and tibialis-anterior muscles (IMCL-T) of 39 pGDM (32 ± 2 years, waist-to-hip ratio 0.81 ± 0.01) and 22 women with normal glucose tolerance (NGT; 31 ± 1 years, 0.76 ± 0.02) at 46 months after delivery. Body fat mass (BFM) was assessed from bioimpedance analysis, insulin sensitivity index (SI), and glucose effectiveness (SG) from insulin-modified frequently sampled glucose tolerance tests. pGDM exhibited 45% increased BFM, 35% reduced SI and SG (P < 0.05), and 40% (P < 0.05) and 55% (P < 0.005) higher IMCL-S and IMCL-T, respectively. IMCL related to body fat (BFM P < 0.005, leptin P < 0.03), but only IMCL-T correlated (P < 0.03) with SI and glucose tolerance index independent of BMI. Insulin-resistant pGDM (n = 17) had higher IMCL-S (+66%) and IMCL-T (+86%) than NGT and insulin-sensitive pGDM (+28%). IMCL were also higher (P < 0.005, P = 0.05) in insulin-sensitive pGDM requiring insulin treatment during pregnancy and inversely related to the gestational week of GDM diagnosis. Thus, IMCL-T reflects insulin sensitivity, whereas IMCL-S relates to obesity. IMCL could serve as an additional parameter of increased diabetes risk because it identifies insulin-resistant pGDM and those who were diagnosed earlier and/or required insulin during pregnancy.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Kautzky-Willer, D. Bancher-Todesca, R. Weitgasser, T. Prikoszovich, H. Steiner, N. Shnawa, G. Schernthaner, R. Birnbacher, B. Schneider, Ch. Marth, et al.
The Impact of Risk Factors and More Stringent Diagnostic Criteria of Gestational Diabetes on Outcomes in Central European Women
J. Clin. Endocrinol. Metab.,
May 1, 2008;
93(5):
1689 - 1695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Friedman, J. P. Kirwan, M. Jing, L. Presley, and P. M. Catalano
Increased Skeletal Muscle Tumor Necrosis Factor-{alpha} and Impaired Insulin Signaling Persist in Obese Women With Gestational Diabetes Mellitus 1 Year Postpartum
Diabetes,
March 1, 2008;
57(3):
606 - 613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-P. St-Onge, B. R Newcomer, S. Buchthal, I. Aban, D. B Allison, A. Bosarge, and B. Gower
Intramyocellular lipid content is lower with a low-fat diet than with high-fat diets, but that may not be relevant for health
Am. J. Clinical Nutrition,
November 1, 2007;
86(5):
1316 - 1322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Buchanan, A. Xiang, S. L. Kjos, and R. Watanabe
What Is Gestational Diabetes?
Diabetes Care,
July 1, 2007;
30(Supplement_2):
S105 - S111.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Kitzmiller, L. Dang-Kilduff, and M. M. Taslimi
Gestational Diabetes After Delivery: Short-term management and long-term risks
Diabetes Care,
July 1, 2007;
30(Supplement_2):
S225 - S235.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Carr, K. M. Utzschneider, R. L. Hull, J. Tong, T. M. Wallace, K. Kodama, J. B. Shofer, S. R. Heckbert, E. J. Boyko, W. Y. Fujimoto, et al.
Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes.
Diabetes Care,
September 1, 2006;
29(9):
2078 - 2083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Nadeau, L. B. Ehlers, L. E. Aguirre, R. L. Moore, K. N. Jew, H. K. Ortmeyer, B. C. Hansen, J. E. B. Reusch, and B. Draznin
Exercise training and calorie restriction increase SREBP-1 expression and intramuscular triglyceride in skeletal muscle
Am J Physiol Endocrinol Metab,
July 1, 2006;
291(1):
E90 - E98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Larson-Meyer, L. K. Heilbronn, L. M. Redman, B. R. Newcomer, M. I. Frisard, S. Anton, S. R. Smith, A. Alfonso, E. Ravussin, and the Pennington CALERIE Team
Effect of Calorie Restriction With or Without Exercise on Insulin Sensitivity, {beta}-Cell Function, Fat Cell Size, and Ectopic Lipid in Overweight Subjects.
Diabetes Care,
June 1, 2006;
29(6):
1337 - 1344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Brehm, K. Thomaseth, E. Bernroider, P. Nowotny, W. Waldhausl, G. Pacini, and M. Roden
The Role of Endocrine Counterregulation for Estimating Insulin Sensitivity from Intravenous Glucose Tolerance Tests
J. Clin. Endocrinol. Metab.,
June 1, 2006;
91(6):
2272 - 2278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Stadler, C. Anderwald, T. Karer, A. Tura, T. Kastenbauer, M. Auinger, C. Bieglmayer, O. Wagner, F. Kronenberg, P. Nowotny, et al.
Increased Plasma Amylin in Type 1 Diabetic Patients After Kidney and Pancreas Transplantation: A sign of impaired {beta}-cell function?
Diabetes Care,
May 1, 2006;
29(5):
1031 - 1038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Jensen
Adipose tissue as an endocrine organ: implications of its distribution on free fatty acid metabolism
Eur. Heart J. Suppl.,
May 1, 2006;
8(suppl_B):
B13 - B19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bernroider, A. Brehm, M. Krssak, C. Anderwald, Z. Trajanoski, G. Cline, G. I. Shulman, and M. Roden
The Role of Intramyocellular Lipids during Hypoglycemia in Patients with Intensively Treated Type 1 Diabetes
J. Clin. Endocrinol. Metab.,
October 1, 2005;
90(10):
5559 - 5565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Torriani, B. J. Thomas, E. F. Halpern, M. E. Jensen, D. I. Rosenthal, and W. E. Palmer
Intramyocellular Lipid Quantification: Repeatability with 1H MR Spectroscopy
Radiology,
August 1, 2005;
236(2):
609 - 614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Kashyap, R. Belfort, R. Berria, S. Suraamornkul, T. Pratipranawatr, J. Finlayson, A. Barrentine, M. Bajaj, L. Mandarino, R. DeFronzo, et al.
Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes
Am J Physiol Endocrinol Metab,
September 1, 2004;
287(3):
E537 - E546.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. C. van Loon, R. Koopman, R. Manders, W. van der Weegen, G. P. van Kranenburg, and H. A. Keizer
Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes
Am J Physiol Endocrinol Metab,
September 1, 2004;
287(3):
E558 - E565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Cree, B. R. Newcomer, C. S. Katsanos, M. Sheffield-Moore, D. Chinkes, A. Aarsland, R. Urban, and R. R. Wolfe
Intramuscular and Liver Triglycerides Are Increased in the Elderly
J. Clin. Endocrinol. Metab.,
August 1, 2004;
89(8):
3864 - 3871.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Hanusch-Enserer, E. Cauza, G. Brabant, A. Dunky, H. Rosen, G. Pacini, H. Tuchler, R. Prager, and M. Roden
Plasma Ghrelin in Obesity before and after Weight Loss after Laparoscopical Adjustable Gastric Banding
J. Clin. Endocrinol. Metab.,
July 1, 2004;
89(7):
3352 - 3358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Winzer, O. Wagner, A. Festa, B. Schneider, M. Roden, D. Bancher-Todesca, G. Pacini, T. Funahashi, and A. Kautzky-Willer
Plasma Adiponectin, Insulin Sensitivity, and Subclinical Inflammation in Women With Prior Gestational Diabetes Mellitus
Diabetes Care,
July 1, 2004;
27(7):
1721 - 1727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Driscoll, G. E. Meininger, K. Ljungquist, C. Hadigan, M. Torriani, A. Klibanski, W. R. Frontera, and S. Grinspoon
Differential Effects of Metformin and Exercise on Muscle Adiposity and Metabolic Indices in Human Immunodeficiency Virus-Infected Patients
J. Clin. Endocrinol. Metab.,
May 1, 2004;
89(5):
2171 - 2178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Romano, M. T. Guagnano, G. Pacini, S. Vigneri, A. Falco, M. Marinopiccoli, M. R. Manigrasso, S. Basili, and G. Davi
Association of Inflammation Markers with Impaired Insulin Sensitivity and Coagulative Activation in Obese Healthy Women
J. Clin. Endocrinol. Metab.,
November 1, 2003;
88(11):
5321 - 5326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. C. van Loon, V. B. Schrauwen-Hinderling, R. Koopman, A. J. M. Wagenmakers, M. K. C. Hesselink, G. Schaart, M. E. Kooi, and W. H. M. Saris
Influence of prolonged endurance cycling and recovery diet on intramuscular triglyceride content in trained males
Am J Physiol Endocrinol Metab,
October 1, 2003;
285(4):
E804 - E811.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Diabetes Association.
|
|
| |
|